NEW YORK (CBSNEWS.COM) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

Currently all COVID-19 treatments used in the U.S. require an IV or injection.

♦♦♦ Click Here For More Details On The Story At cbsnews.com ♦♦♦

 

CBSDFW.com Staff